Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1984;17(Suppl 1):21S–27S. doi: 10.1111/j.1365-2125.1984.tb02424.x

Effects of β-adrenoceptor antagonists on the pharmacokinetics of lignocaine

G T Tucker, N D S Bax, M S Lennard, S Al-Asady, H S Bharaj, H F Woods
PMCID: PMC1463282  PMID: 6146336

Abstract

1 In theory, β-adrenoceptor antagonists could lower the clearance of free lignocaine in three ways (a) by decreasing hepatic blood flow, (b) by competing for plasma binding sites or (c) by inhibiting the enzymes responsible for metabolising lignocaine.

2 The first mechanism has been demonstrated for propranolol and is probably common to all agents lacking intrinsic sympathomimetic activity.

3 The second mechanism is discounted by data showing that propranolol, one of the more highly bound β-adrenoceptor antagonists, does not alter the free fraction of lignocaine in plasma.

4 In vitro studies support the third mechanism for the more lipid-soluble β-adrenoceptor antagonists, as does the fact that observed decreases in the clearance of lignocaine in vivo are generally greater than the anticipated maximum lowering of hepatic blood flow.

Keywords: β-adrenoceptor blockers, lignocaine, pharmacokinetics, propranolol

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barchowsky A., Shand D. G., Stargel W. W., Wagner G. S., Routledge P. A. On the role of alpha 1-acid glycoprotein in lignocaine accumulation following myocardial infarction. Br J Clin Pharmacol. 1982 Mar;13(3):411–415. doi: 10.1111/j.1365-2125.1982.tb01394.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bauer L. A., Brown T., Gibaldi M., Hudson L., Nelson S., Raisys V., Shea J. P. Influence of long-term infusions on lidocaine kinetics. Clin Pharmacol Ther. 1982 Apr;31(4):433–437. doi: 10.1038/clpt.1982.56. [DOI] [PubMed] [Google Scholar]
  3. Bax N. D., Lennard M. S., Tucker G. T. Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists. Br J Clin Pharmacol. 1981 Dec;12(6):779–784. doi: 10.1111/j.1365-2125.1981.tb01306.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bax N. D., Tucker G. T., Woods H. F. Lignocaine and indocyanine green kinetics in patients following myocardial infarction. Br J Clin Pharmacol. 1980 Oct;10(4):353–361. doi: 10.1111/j.1365-2125.1980.tb01771.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Branch R. A., Shand D. G., Wilkinson G. R., Nies A. S. The reduction of lidocaine clearance by dl-propranolol: an example of hemodynamic drug interaction. J Pharmacol Exp Ther. 1973 Feb;184(2):515–519. [PubMed] [Google Scholar]
  6. Browning S., Lawrence D., Livingston A., Morris B. Interactions of drugs active at opiate receptors and drugs active at alpha 2-receptors on various test systems. Br J Pharmacol. 1982 Nov;77(3):487–491. doi: 10.1111/j.1476-5381.1982.tb09322.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chen C. P., Vu V. T., Cohen S. D. Lidocaine uptake in isolated rat hepatocytes and effects of dl-propranolol. Toxicol Appl Pharmacol. 1980 Aug;55(1):162–168. doi: 10.1016/0041-008x(80)90232-x. [DOI] [PubMed] [Google Scholar]
  8. Conrad K. A., Byers J. M., 3rd, Finley P. R., Burnham L. Lidocaine elimination: effects of metoprolol and of propranolol. Clin Pharmacol Ther. 1983 Feb;33(2):133–138. doi: 10.1038/clpt.1983.20. [DOI] [PubMed] [Google Scholar]
  9. DeSilva R. A., Hennekens C. H., Lown B., Casscells W. Lignocaine prophylaxis in acute myocardial infarction: an evaluation of randomised trials. Lancet. 1981 Oct 17;2(8251):855–858. doi: 10.1016/s0140-6736(81)91116-8. [DOI] [PubMed] [Google Scholar]
  10. Deacon C. S., Lennard M. S., Bax N. D., Woods H. F., Tucker G. T. Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility. Br J Clin Pharmacol. 1981 Sep;12(3):429–431. doi: 10.1111/j.1365-2125.1981.tb01240.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Graham C. F., Turner W. M., Jones J. K. Lidocaine-propranolol interactions. N Engl J Med. 1981 May 21;304(21):1301–1301. doi: 10.1056/nejm198105213042117. [DOI] [PubMed] [Google Scholar]
  12. Greenblatt D. J., Franke K., Huffman D. H. Impairment of antipyrine clearance in humans by propranolol. Circulation. 1978 Jun;57(6):1161–1164. doi: 10.1161/01.cir.57.6.1161. [DOI] [PubMed] [Google Scholar]
  13. HOLLUNGER G. On the metabolism of lidocaine. I. The properties of the enzyme system responsible for the oxidative metabolism of lidocaine. Acta Pharmacol Toxicol (Copenh) 1961;17:356–364. doi: 10.1111/j.1600-0773.1961.tb01654.x. [DOI] [PubMed] [Google Scholar]
  14. HOLLUNGER G. On the metabolism of lidocaine. II. The biotransformation of lidocaine. Acta Pharmacol Toxicol (Copenh) 1961;17:365–373. doi: 10.1111/j.1600-0773.1961.tb01655.x. [DOI] [PubMed] [Google Scholar]
  15. Keenaghan J. B., Boyes R. N. The tissue distribution, metabolism and excretion of lidocaine in rats, guinea pigs, dogs and man. J Pharmacol Exp Ther. 1972 Feb;180(2):454–463. [PubMed] [Google Scholar]
  16. Koo A., Liang I. Y. beta 2-Adrenoceptors in rat liver microcirculation. Clin Exp Pharmacol Physiol. 1979 Jul-Aug;6(4):403–407. doi: 10.1111/j.1440-1681.1979.tb00027.x. [DOI] [PubMed] [Google Scholar]
  17. LeLorier J., Moisan R., Gagné J., Caillé G. Effect of the duration of infusion on the disposition of lidocaine in dogs. J Pharmacol Exp Ther. 1977 Dec;203(3):507–511. [PubMed] [Google Scholar]
  18. Lennard M. S., Tucker G. T., Woods H. F. Time-dependent kinetics of lignocaine in the isolated perfused rat liver. J Pharmacokinet Biopharm. 1983 Apr;11(2):165–182. doi: 10.1007/BF01061847. [DOI] [PubMed] [Google Scholar]
  19. Martin M. A., Bax N. D., Tucker G. T., Ward J. W. Disopyramide and lignocaine. A comparison of cardiac effects using echocardiography. Br J Clin Pharmacol. 1980 Sep;10(3):237–244. doi: 10.1111/j.1365-2125.1980.tb01750.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. McDowell D. E., Grant M. A., Gustafson R. A. Single arterial trunk arising from the aortic arch. Circulation. 1980 Jul;62(1):181–182. doi: 10.1161/01.cir.62.1.181. [DOI] [PubMed] [Google Scholar]
  21. McNamara P. J., Slaughter R. L., Pieper J. A., Wyman M. G., Lalka D. Factors influencing serum protein binding of lidocaine in humans. Anesth Analg. 1981 Jun;60(6):395–400. [PubMed] [Google Scholar]
  22. Nation R. L., Triggs E. J., Selig M. Lignocaine kinetics in cardiac patients and aged subjects. Br J Clin Pharmacol. 1977 Aug;4(4):439–448. doi: 10.1111/j.1365-2125.1977.tb00759.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ochs H. R., Carstens G., Greenblatt D. J. Reduction in lidocaine clearance during continuous infusion and by coadministration of propranolol. N Engl J Med. 1980 Aug 14;303(7):373–377. doi: 10.1056/NEJM198008143030705. [DOI] [PubMed] [Google Scholar]
  24. Pfeifer H. J., Greenblatt D. J., Koch-Weser J. Clinical use and toxicity of intravenous lidocaine. A report from the Boston Collaborative Drug Surveillance Program. Am Heart J. 1976 Aug;92(2):168–173. doi: 10.1016/s0002-8703(76)80252-9. [DOI] [PubMed] [Google Scholar]
  25. Piafsky K. M., Borgá O., Odar-Cederlöf I., Johansson C., Sjöqvist F. Increased plasma protein binding of propranolol and chlorpromazine mediated by disease-induced elevations of plasma alpha1 acid glycoprotein. N Engl J Med. 1978 Dec 28;299(26):1435–1439. doi: 10.1056/NEJM197812282992604. [DOI] [PubMed] [Google Scholar]
  26. Prescott L. F., Adjepon-Yamoah K. K., Talbot R. G. Impaired Lignocaine metabolism in patients with myocardial infarction and cardiac failure. Br Med J. 1976 Apr 17;1(6015):939–941. doi: 10.1136/bmj.1.6015.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Regårdh C. G. Pharmacokinetic aspects of some beta-adrenoceptor blocking drugs. Acta Med Scand Suppl. 1982;665:49–60. doi: 10.1111/j.0954-6820.1982.tb00408.x. [DOI] [PubMed] [Google Scholar]
  28. Rossi P. R., Yusuf S., Ramsdale D., Furze L., Sleight P. Reduction of ventricular arrhythmias by early intravenous atenolol in suspected acute myocardial infarction. Br Med J (Clin Res Ed) 1983 Feb 12;286(6364):506–510. doi: 10.1136/bmj.286.6364.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Routledge P. A., Barchowsky A., Bjornsson T. D., Kitchell B. B., Shand D. G. Lidocaine plasma protein binding. Clin Pharmacol Ther. 1980 Mar;27(3):347–351. doi: 10.1038/clpt.1980.46. [DOI] [PubMed] [Google Scholar]
  30. Routledge P. A., Stargel W. W., Wagner G. S., Shand D. G. Increased alpha-1-acid glycoprotein and lidocaine disposition in myocardial infarction. Ann Intern Med. 1980 Nov;93(5):701–704. doi: 10.7326/0003-4819-93-5-701. [DOI] [PubMed] [Google Scholar]
  31. Rydén L., Ariniego R., Arnman K., Herlitz J., Hjalmarson A., Holmberg S., Reyes C., Smedgård P., Svedberg K., Vedin A. A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med. 1983 Mar 17;308(11):614–618. doi: 10.1056/NEJM198303173081102. [DOI] [PubMed] [Google Scholar]
  32. Schneck D. W., Pritchard J. F. The inhibitory effect of propranolol pretreatment on its own metabolism in the rat. J Pharmacol Exp Ther. 1981 Sep;218(3):575–581. [PubMed] [Google Scholar]
  33. Svendsen T. L., Carlsen J. E., Hartling O., McNair A., Trap-Jensen J. A comparison of the acute haemodynamic effects of propranolol and pindolol at rest and during supine exercise in man. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):465s–468s. doi: 10.1042/cs059465s. [DOI] [PubMed] [Google Scholar]
  34. Svendsen T. L., Hartling O. J., Trap-Jensen J., McNair A., Bliddal J. Adrenergic beta receptor blockade: hemodynamic importance of intrinsic sympathomimetic activity at rest. Clin Pharmacol Ther. 1981 Jun;29(6):711–718. doi: 10.1038/clpt.1981.100. [DOI] [PubMed] [Google Scholar]
  35. Svendsen T. L., Hartling O., Trap-Jensen J. Immediate haemodynamic effects of propranolol, practolol, pindolol, atenolol and ICI 89,406 in healthy volunteers. Eur J Clin Pharmacol. 1979 May 21;15(4):223–228. doi: 10.1007/BF00618509. [DOI] [PubMed] [Google Scholar]
  36. Svendsen T. L., Tangø M., Waldorff S., Steiness E., Trap-Jensen J. Effects of propranolol and pindolol on plasma lignocaine clearance in man. Br J Clin Pharmacol. 1982;13(Suppl 2):223S–226S. doi: 10.1111/j.1365-2125.1982.tb01915.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Tsukiyama H., Otsuka K., Higuma K. Effects of beta-adrenoceptor antagonists on central haemodynamics in essential hypertension. Br J Clin Pharmacol. 1982;13(Suppl 2):269S–278S. doi: 10.1111/j.1365-2125.1982.tb01924.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Tucker G. T., Bax N. D., Lennard M. S., Crewe K., Woods H. F. Lack of effect of atenolol on antipyrine clearance. Br J Clin Pharmacol. 1982 Nov;14(5):743–744. doi: 10.1111/j.1365-2125.1982.tb04967.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Tucker G. T., Boas R. A. Pharmacokinetic aspects of intravenous regional anesthesia. Anesthesiology. 1971 Jun;34(6):538–549. doi: 10.1097/00000542-197106000-00014. [DOI] [PubMed] [Google Scholar]
  40. Tucker G. T., Boyes R. N., Bridenbaugh P. O., Moore D. C. Binding of anilide-type local anesthetics in human plasma. I. Relationships between binding, physicochemical properties, and anesthetic activity. Anesthesiology. 1970 Sep;33(3):287–303. doi: 10.1097/00000542-197009000-00002. [DOI] [PubMed] [Google Scholar]
  41. Tucker G. T., Mather L. E. Clinical pharmacokinetics of local anaesthetics. Clin Pharmacokinet. 1979 Jul-Aug;4(4):241–278. doi: 10.2165/00003088-197904040-00001. [DOI] [PubMed] [Google Scholar]
  42. Tucker G. T., Wiklund L., Berlin-Wahlen A., Mather L. E. Hepatic clearance of local anesthetics in man. J Pharmacokinet Biopharm. 1977 Apr;5(2):111–122. doi: 10.1007/BF01066215. [DOI] [PubMed] [Google Scholar]
  43. Vicuna N., Lalka D., Burrow S. R., McLean A. J., du Souich P., McNay J. L. Dose-dependent pharmacokinetic behavior of lidocaine in the conscious dog. Res Commun Chem Pathol Pharmacol. 1978 Dec;22(3):485–491. [PubMed] [Google Scholar]
  44. Vu V. T., Chen C. P. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver. Drug Metab Dispos. 1982 Jul-Aug;10(4):350–355. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES